LSTA

Lisata Therapeutics, Inc. · NASDAQ

$1.03USDCS band Weak

↓ $0.03 (2.83%) Today

As of Oct 27, 1:51 PM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$11.1M
Volume
59K
52W High
$5.07
52W Low
$0.9604
PE Ratio
—
Avg Vol
212.4K
As of 10/26/26
Div Yield
—
Beta
0.63
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about LSTA?

Latest news

News ›

GlobeNewswire Inc.

Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. Baldwin Group (BWIN) is being sold for $32.50 per share, Lisata Therapeutics (LSTA) for $4.00 per share plus contingent value rights, and ACV for $10.50 per share. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.